My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Prevention of cardiovascular disease.

    Bloomgarden ZT.

    Diabetes Care. 2007 Feb;30(2):423-31. No abstract available. PMID: 17259524 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome.

    Duncan GE.

    Curr Diab Rep. 2006 Feb;6(1):29-35. Review.PMID: 16522278 [PubMed - indexed for MEDLINE]Related articles

    3.

    Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.

    De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ.

    Diabetes Care. 2007 Oct;30(10):2511-3. Epub 2007 Jul 12. No abstract available. PMID: 17626892 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty.

    Dagogo-Jack S.

    Diabetes Care. 2005 Apr;28(4):971-2. Review. No abstract available. PMID: 15793208 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes mellitus. Proceedings of a symposium. November 6-8, 2002, New York, New York, USA.

    [No authors listed]

    Am J Med. 2003 Dec 8;115 Suppl 8A:1S-120S. No abstract available. PMID: 14678858 [PubMed - indexed for MEDLINE]Related articles

    6.

    European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

    Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL; Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A.

    Eur Heart J. 2007 Oct;28(19):2375-414. Epub 2007 Aug 28. No abstract available. PMID: 17726041 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cardiovascular disease prevention tailored for women.

    Engberding N, Wenger NK.

    Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1123-34. Review.PMID: 18793115 [PubMed - indexed for MEDLINE]Related articles

    8.

    European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS).

    Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. No abstract available. PMID: 17726407 [PubMed - indexed for MEDLINE]Related articles

    9.

    European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).

    Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available. PMID: 17726406 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

    Goodarzi MO, Psaty BM.

    JAMA. 2008 Nov 5;300(17):2051-3. No abstract available. PMID: 18984894 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dyslipidemia in the metabolic syndrome in children.

    Gidding SS.

    J Cardiometab Syndr. 2006 Summer;1(4):282-5. Review.PMID: 17679808 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cardiovascular disease in diabetes.

    Bloomgarden ZT.

    Diabetes Care. 2008 Jun;31(6):1260-6. No abstract available. PMID: 18509144 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cardiovascular disease.

    Bloomgarden ZT.

    Diabetes Care. 2006 May;29(5):1160-6. Review. No abstract available. PMID: 16644657 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impact of physical activity on cardiovascular risk factors in children with type 1 diabetes: a multicenter study of 23,251 patients.

    Herbst A, Kordonouri O, Schwab KO, Schmidt F, Holl RW; DPV Initiative of the German Working Group for Pediatric Diabetology Germany.

    Diabetes Care. 2007 Aug;30(8):2098-100. Epub 2007 Apr 27. No abstract available. PMID: 17468347 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.

    Hoerger TJ, Ahmann AJ.

    J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. Review.PMID: 18240890 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Primary prevention of cardiovascular disease in people with dysglycemia.

    Bianchi C, Miccoli R, Penno G, Del Prato S.

    Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. Review.PMID: 18227487 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

    Basile J, Houston M, Ferrario CM.

    J Cardiometab Syndr. 2006 Fall;1(5):358-61. No abstract available. PMID: 17679795 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

    Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G.

    Diabetes Care. 2007 May;30(5):1212-8. Epub 2007 Feb 2.PMID: 17277038 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.

    Mazzone T.

    Am J Med. 2007 Sep;120(9 Suppl 2):S26-32.PMID: 17826043 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical implications of the metabolic syndrome.

    Ceska R.

    Diab Vasc Dis Res. 2007 Sep;4 Suppl 3:S2-4.PMID: 17935057 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity